Transgene Biotek

{
  "main_header": {
    "sid": 408336,
    "name": "Transgene Biotek",
    "stock_name": "Transgene Biotek",
    "full_name": "Transgene Biotek Ltd",
    "name_url": "stocks-analysis/transgene-biotek",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2.16",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "2.16",
    "mcapval": "17.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 526139,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE773D01018",
    "curr_date": "Feb 09",
    "curr_time": "",
    "bse_nse_vol": "62.38 k",
    "exc_status": "Active",
    "traded_date": "Feb 09, 2026",
    "traded_date_str": "2026 02 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/transgene-biotek-408336-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Transgene Biotek Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-transgene-biotek-ltd-3810211",
        "imagepath": "",
        "date": "2026-01-29 23:15:54",
        "description": "The next results date for Transgene Biotek Ltd is scheduled for 13 February 2026...."
      },
      {
        "title": "Why is Transgene Biotek falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-transgene-biotek-fallingrising-3757684",
        "imagepath": "",
        "date": "2025-12-13 00:55:49",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Despite the recent surge, Transgene Biotek’s stock remains under pressure over longer time horizons. Year-to-date, the stock has declined by 56.22%, significantly underperforming the Sensex, which has gained 9.12% during the same period. Over the past year, the stock has fallen by 57.89%, contrasting with the Sensex’s 4.89% rise. Even over five years, the stock has declined by 41.83%, while the benchmark index has appreciated by nearly 85%. These figures highlight the challenges the company has faced in maintaining investor confidence over time.</p>\n<p>However, the recent price action on 12-Dec marks a reversal from a short-term downtrend. After three consecutive days of declines, the stock’s 9.93% gain indicates renewed buying interes..."
      },
      {
        "title": "How has been the historical performance of Transgene Biotek?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-transgene-biotek-3702753",
        "imagepath": "",
        "date": "2025-11-14 23:31:50",
        "description": "Answer:\nThe historical performance of Transgene Biotek shows a gradual increase in net sales, rising from 0.06 Cr in Mar'23 to 0.26 Cr in Mar'25. However, the company has consistently reported negative operating profits, with an operating profit of -1.13 Cr in Mar'25, indicating a worsening trend compared to -0.62 Cr in Mar'24. The total expenditure has also increased significantly, reaching 1.39 Cr in Mar'25 from 0.85 Cr in Mar'24. The profit before tax has remained negative, with a loss of -0.68 Cr in Mar'25, slightly worse than -0.66 Cr in Mar'24. The net profit after tax also reflects this trend, showing a loss of -0.68 Cr in Mar'25 compared to -0.66 Cr in Mar'24. The company's total liabilities have remained relatively stable at 142.33 Cr in Mar'24, down from 142.36 Cr in Mar'23. The cash flow from operating activities has been stagnant, with no cash inflow reported in recent years.\n\nBreakdown:\nTransge..."
      }
    ],
    "total": 79,
    "sid": "408336",
    "stock_news_url": "https://www.marketsmojo.com/news/transgene-biotek-408336"
  },
  "announcements": [
    {
      "caption": "Declaration Under Clause 36 Of Listing Agreement With BSE PROHIBITORY ORDER NO. RRD/SRO/1166/2026/1 - SEBI",
      "datetime": "03-Feb-2026",
      "details": "General Announcements",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Intimation Of The Board Meeting To Be Held On Friday 13Th February 2026",
      "datetime": "28-Jan-2026",
      "details": "Transgene Biotek Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve 1) To consider and approve the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 31st December 2025. 2) To consider and approve the Limited Review Report (Standalone & Consolidated) for the quarter ended 31st December 2025. 3) To transact such other business as may be required.",
      "source": "BSE"
    },
    {
      "caption": "Statement Of Deviation & Variation",
      "datetime": "12-Jan-2026",
      "details": "Statement of Deviation & Variation",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "13 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

When is the next results date for Transgene Biotek Ltd?

2026-01-29 23:15:54

The next results date for Transgene Biotek Ltd is scheduled for 13 February 2026....

Read full news article

Why is Transgene Biotek falling/rising?

2025-12-13 00:55:49

Recent Price Movement and Market Context

Despite the recent surge, Transgene Biotek’s stock remains under pressure over longer time horizons. Year-to-date, the stock has declined by 56.22%, significantly underperforming the Sensex, which has gained 9.12% during the same period. Over the past year, the stock has fallen by 57.89%, contrasting with the Sensex’s 4.89% rise. Even over five years, the stock has declined by 41.83%, while the benchmark index has appreciated by nearly 85%. These figures highlight the challenges the company has faced in maintaining investor confidence over time.

However, the recent price action on 12-Dec marks a reversal from a short-term downtrend. After three consecutive days of declines, the stock’s 9.93% gain indicates renewed buying interes...

Read full news article

How has been the historical performance of Transgene Biotek?

2025-11-14 23:31:50

Answer: The historical performance of Transgene Biotek shows a gradual increase in net sales, rising from 0.06 Cr in Mar'23 to 0.26 Cr in Mar'25. However, the company has consistently reported negative operating profits, with an operating profit of -1.13 Cr in Mar'25, indicating a worsening trend compared to -0.62 Cr in Mar'24. The total expenditure has also increased significantly, reaching 1.39 Cr in Mar'25 from 0.85 Cr in Mar'24. The profit before tax has remained negative, with a loss of -0.68 Cr in Mar'25, slightly worse than -0.66 Cr in Mar'24. The net profit after tax also reflects this trend, showing a loss of -0.68 Cr in Mar'25 compared to -0.66 Cr in Mar'24. The company's total liabilities have remained relatively stable at 142.33 Cr in Mar'24, down from 142.36 Cr in Mar'23. The cash flow from operating activities has been stagnant, with no cash inflow reported in recent years. Breakdown: Transge...

Read full news article

View All News